SOURCE: Astro-Med, Inc.

Astro-Med, Inc.

August 18, 2009 16:00 ET

Astro-Med Reports Sales and Net Income in the Second Quarter; Directors Declare Regular Cash Dividend

WEST WARWICK, RI--(Marketwire - August 18, 2009) - Astro-Med, Inc. (NASDAQ: ALOT) reports net income of $585,000, equal to 8 cents per diluted share, on sales of $16,416,000 for the Second Quarter ended August 1, 2009. The Company reported net income of $1,154,000, equal to 15 cents per diluted share, on sales of $19,784,000 for the comparable period of the prior year. Unfavorable foreign exchange currency rates lowered this year's Second Quarter sales by approximately $446,000, or 2.7%, when compared to the previous year.

For the six months ended August 1, 2009, Astro-Med reported net income of $354,000, equal to 5 cents per diluted share, on sales of $31,093,000. During the comparable six-month period of the prior year, net income was $2,051,000, equal to 27 cents per diluted share, on sales of $38,472,000. Unfavorable foreign exchange currency rates reduced this year's six-month sales by approximately $1,189,000, or 3.8%, as compared to the prior year.

The Company's balance sheet remains strong with a cash and marketable securities position of $21,955,000, a current ratio of 7.0:1, and zero debt.

Commenting on the results, Albert W. Ondis, Chief Executive Officer, said: "We are quite pleased with our profitable Second Quarter results after the recession-induced loss in the First Quarter. Our strong performance in the quarter is the result of vigorous selling and marketing activities which raised new customer orders by 16% and sales by 12% over the First Quarter, combined with effective expense reduction and control.

"Although there are signs that our markets are recovering, and we expect to report continued improvements as the year progresses, we will continue our recession watch for the foreseeable future," Ondis continued.

Three-Year Strategic Plan Approved

Ondis stated, "On August 17, 2009 the Astro-Med board of directors approved the new 'Three-Year Strategic Plan,' which was developed over a three-month period during the quarter. Astro-Med, Inc. employees from all levels and our branches in Canada and Europe participated in the development of the plan which was overseen by the Board at a special meeting in June. The plan calls for growth through internal development as well as by acquisition. Consistent with the plan, we have maintained a high level of R&D activities and we will soon announce some exciting new products which will contribute to our growth. Our search for suitable acquisitions is underway and we will make announcements as appropriate."

Astro-Med, Inc. Directors Declare Regular Cash Dividend

On August 17, 2009, the Directors of Astro-Med, Inc. declared the regular quarterly cash dividend of $0.06 per share, payable on October 1, 2009 to shareholders of record as of September 11, 2009.

Second Quarter Conference Call to be Held Wednesday, August 19, 2009

The Second Quarter conference call will be held on Wednesday, August 19, 2009, at 11:00 AM EDT. It will be broadcast in real time on the Internet and will be available through the Investing section of our website. We invite you to log on and listen in real time on August 19th or to participate in the conference call by dialing 1-877-941-1466 and referencing ID number 4116728. Following the live broadcast, a webcast of the recorded call will be available for ten days at www.Astro-MedInc.com.

          Astro-Med, Inc. Consolidated Statements of Operations
                  In Thousands Except for Per Share Data
                                (Unaudited)

                                 Three-Months Ended     Six-Months Ended
                                August 1,  August 2,  August 1,  August 2,
                                  2009       2008       2009       2008
                                ---------  ---------  ---------  ---------
Net Sales                       $  16,416  $  19,784  $  31,093  $  38,472
Gross Profit                        6,951      8,681     12,763     16,868
                                     42.3%      43.9%      41.0%      43.8%
Operating Expenses:
   Selling & Marketing              3,724      4,343      7,607      8,764
   Research & Development           1,175      1,199      2,402      2,425
   General & Administrative         1,166      1,210      2,328      2,456
                                ---------  ---------  ---------  ---------
                                    6,065      6,752     12,337     13,645

Operating Income                      886      1,929        426      3,223
                                      5.4%       9.7%       1.4%       8.4%

Other Income, Net                      14         61        119        237
                                ---------  ---------  ---------  ---------

Income Before Taxes                   900      1,990        545      3,460

Income Tax Provision                  315        836        191      1,409
                                ---------  ---------  ---------  ---------

Net Income                      $     585  $   1,154  $     354  $   2,051
                                =========  =========  =========  =========

Net Income Per Share - Basic    $    0.08  $    0.16  $    0.05  $    0.29
                                =========  =========  =========  =========
Net Income Per Share - Diluted  $    0.08  $    0.15  $    0.05  $    0.27
                                =========  =========  =========  =========

Weighted Average Number of
 Common Shares  - Basic             7,148      6,999      7,118      6,966
Weighted Average Number of
 Common Shares  - Diluted           7,343      7,523      7,316      7,482

Dividends Declared Per Common
 Share                          $    0.06  $    0.06  $    0.12  $    0.12




                        Selected Balance Sheet Data
                               In Thousands
                                (Unaudited)

                                 As of        As of
                               August 1,    January 31,
                                  2009         2009
                              -----------  -----------

Cash & Marketable
 Securities(1)                $    21,955  $    22,104

Current Assets                $    47,832  $    48,023

Total Assets                  $    61,678  $    62,155

Current Liabilities           $     6,840  $     7,904

Shareholders' Equity          $    52,001  $    51,471

(1)  Includes investment securities classified as non-current

About Astro-Med, Inc.

Astro-Med, Inc. is a leading manufacturer of specialty high tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments. Astro-Med, Inc. products are sold under the brand names Astro-Med®, Grass® Technologies, and QuickLabel® Systems, and are employed around the world in a wide range of aerospace, medical, military, industrial, and packaging applications. Astro-Med Inc. is a member of the Russell Microcap® Index. Additional information is available by visiting www.Astro-MedInc.com.

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2009 Annual Report and its annual and quarterly filings with the Securities and Exchange Commission.

Contact Information

  • Contact:
    Albert W. Ondis
    CEO
    Joseph P. O'Connell
    CFO
    Astro-Med, Inc.
    Tel: 800-343-4039